학술논문

Bacterial protein azurin as a new candidate drug to treat untreatable breast cancers
Document Type
Conference
Source
1st Portuguese Biomedical Engineering Meeting Bioengineering (ENBENG), 2011. ENBENG 2011. 1st Portuguese Meeting in. :1-4 Mar, 2011
Subject
Bioengineering
Communication, Networking and Broadcast Technologies
Components, Circuits, Devices and Systems
Computing and Processing
Signal Processing and Analysis
Proteins
Breast cancer
Tumors
Peptides
In vitro
azurin
P-cadherin
Protein-Protein interaction
New anticancer agent for breast cancer
Language
Abstract
Azurin is a blue copper protein produced by Pseudomonas aeruginosa. Azurin enters preferentially into cancer cells and forms a complex with p53, stabilizing it and inducing apoptosis. Azurin allows in vivo regression of human melanoma and breast cancer without toxic effects to the animal. Its immunoglobulin-like fold and a large exposed hydrophobic patch confer on it the property of a natural scaffold. This has already been proven for the receptor tyrosine kinase EphB2, since azurin prevents its binding to the ligand ephrinB2. We intend to extend the azurin interaction to cell adhesion molecules (CAMs), particularly P-cadherin. P-cadherin is frequently overexpressed in invasive breast carcinomas and it is a poor prognosis marker. Protein-protein docking results have validated this approach confirming an interaction between both proteins. Thus, natural azurin or derived proteins or peptides could be scaffolds against these proteins in breast cancer cells models, being an interesting new therapeutic tool.